1.
tissue thromboplasti
组织促凝血酶原激酶
2.
thromboplastin antecedent
促凝血酶原激酶先质
3.
plasma throml oplastin antecedant (PTA)
血浆促凝血酶原激酶前体
4.
Electrophysiological evaluation of the safety of injection of tissue plasminogen activator into optic nerve in rabbits
视盘内注射组织凝血酶原激活剂安全性的电生理学评价(英文)
5.
An enzyme in human urine that catalyzes the conversion of plasminogen to plasmin and is used in medicine to dissolve blood clots.
尿激酶人体尿液中的可促使血将酶原转代成血浆酶的酶，用于溶解血凝块的药物中
6.
The Influence of Different Thromboplastins Upon the International Normalised ratio (INR) and the Prothrombin Time Ratio (PTR)
组织凝血活酶对凝血酶原时间比率与国际正常化比率的影响
7.
Injection of tissue plasminogen activator into the optic nerve in an animal model of retinal vein occlusion
视盘内注射组织凝血酶原激活剂治疗视网膜中央静脉阻塞的初步研究(英文)
8.
The Des-γ-carboxy-prothrombin Levels in Serum and Liver Tissue of Hepatocarcinoma and Their Clinical Significance
肝癌血清、组织中脱-γ-羧基凝血酶原水平测定及其临床意义
9.
The Recombinant Human Tissue-type Plasminogen Activator in the Treatment of Deep Venous Thrombosis of the Lower Extremities
重组组织型纤溶酶原激活剂治疗下肢深静脉血栓形成的临床应用
10.
Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
11.
The Studies of the Role of Tissue Plasminogen Activator in Brain Injury after Cerebral Ischemia;
组织纤溶酶原激活物在脑缺血后神经损伤中的作用及其机制研究
12.
Research of the Rho kinase in perihematomal cerebral tissue after experimental intracerebral hemorrhage
实验性脑出血血肿周围组织中Rho激酶的研究
13.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
14.
Expressions of Survivin and uPA in human cerebral gliomas
脑胶质瘤组织中Survivin和尿激酶型纤溶酶原激活物蛋白的表达
15.
Nucleocapsid Protein of SARS-associated Coronavirus Upregulates the Transcription of hfgl2 Prothrombinase/ Fibroleukin Gene;
SARS冠状病毒N蛋白激活hfgl2凝血酶原酶基因的研究
16.
congenital aprothrombinemia
先天性凝血酶原缺乏症
17.
Preliminary Study on DNA Family Shuffling of Tissue-type Plasminogen Activator Genes;
组织型纤溶酶原激活物DNA改组的探索研究
18.
Influence of Aprotinin to Activated Clotting Time and Whole Blood Prothrombin Time during Cardiopulmonary Bypass;
体外循环下抑肽酶对激活的全血凝固时间和全血凝血酶原时间的影响